(Q51606922)

8 April 2018

title

The effect of various blood glucose levels on post-glucagon C-peptide secretion in type 2 (non insulin-dependent) diabetes. (English)

1 reference

8 April 2018

author name string

I Nosari

1

1 reference

8 April 2018

G Lepore

2

1 reference

8 April 2018

M L Maglio

3

1 reference

8 April 2018

F Cortinovis

4

1 reference

8 April 2018

G Pagani

5

1 reference

8 April 2018

publication date

1 February 1992

1 reference

8 April 2018

Journal of Endocrinological Investigation

published in

1 reference

8 April 2018

volume

15

1 reference

8 April 2018

issue

2

1 reference

8 April 2018

page(s)

143-146

1 reference

8 April 2018

https://scigraph.springernature.com/pub.10.1007/bf03348682

exact match

0 references

cites work

C-peptide Response to Glucagon: A Test for the Residual β-cell Function in Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

Plasma and urinary C-peptide in the classification of adult diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

A comparison of serum C-peptide response to intravenous glucagon, and urine C-peptide, as indexes of insulin dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

Relationship of islet function to insulin action in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

Sandostatin, a new analogue of somatostatin, reduces the metabolic changes induced by the nocturnal interruption of continuous subcutaneous insulin infusion in type 1 (insulin-dependent) diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03348682

Immunologic Insulin Resistance

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1569291

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1569291

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF03348682

1 reference

8 April 2018

1 reference

8 April 2018